Dynavax Technologies reported $1.13B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Adma Biologics ADMA:US $ 205.1M 10.57M
Agenus AGEN:US $ 1.22B 664.46M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Amgen AMGN:US $ 140.05B 3.22B
AstraZeneca AZN:LN 113.99B 18.86B
Astrazeneca AZN:US 157.61B 26.53B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
BioSpecifics Technologies BSTC:US 38.8M 6.21M
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Chimerix CMRX:US $ 690M 141.05M
Dynavax Technologies DVAX:US $ 1.13B 15.39M
Gilead Sciences GILD:US $ 86.36B 4.99B
Glaxosmithkline GSK:US 98.75B 9.46B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Idera Pharmaceuticals IDRA:US $ 60.04M 457.74K
Merk MRK:US $ 196918.18M 1780.24M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Nektar Therapeutics NKTR:US $ 3.13B 515.22M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Tg Therapeutics TGTX:US $ 5.51B 1.27B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B